Rosen P P, Ernsberger D
Am J Surg Pathol. 1987 May;11(5):351-8. doi: 10.1097/00000478-198705000-00003.
The prognostic significance of metaplasia in mammary carcinoma has not been well defined. Pseudosarcomatous metaplasia reportedly has an unfavorable impact on survival. Squamous metaplasia may have less effect on outcome except for the high-grade spindle cell form, which is particularly aggressive. This report describes 11 patients with a low-grade variant of adenosquamous metaplastic carcinoma which has a distinctive combination of glandular and squamous differentiation. The average age of the patients was 59 years (range 42-76). The tumors measured 1.5-3.4 cm (average 2.3) and were grossly hard, tan-yellow, and infiltrative. Follow-up in seven cases treated at least 1 year ago averages 3.5 years (range 1-6 years). Four of eight patients treated by local excision alone developed recurrence in the breast in 1-3.5 years. Negative lymph nodes were found in five axillary dissections. There have been no recurrences after mastectomy performed as primary therapy or for recurrence in seven cases. These findings suggest that patients with the low-grade adenosquamous variant of metaplastic carcinoma have a favorable prognosis. They may be good candidates for breast conservation therapy, but this will require adequate excision followed by primary radiotherapy.
化生在乳腺癌中的预后意义尚未明确界定。据报道,假肉瘤样化生对生存率有不利影响。鳞状化生对预后的影响可能较小,但高级别梭形细胞型除外,该型具有特别强的侵袭性。本报告描述了11例腺鳞化生癌低级别变异型患者,其具有独特的腺性和鳞状分化组合。患者的平均年龄为59岁(范围42 - 76岁)。肿瘤大小为1.5 - 3.4 cm(平均2.3 cm),大体表现为质地硬、棕黄色且呈浸润性。至少在1年前接受治疗的7例患者的随访时间平均为3.5年(范围1 - 6年)。仅接受局部切除的8例患者中有4例在1 - 3.5年内出现乳腺复发。在5例腋窝清扫中发现淋巴结阴性。作为初始治疗或针对复发进行乳房切除的7例患者均未出现复发。这些发现表明,腺鳞化生癌低级别变异型患者预后良好。他们可能是保乳治疗的合适人选,但这需要充分切除后进行根治性放疗。